Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Therapeutic Drug Monitoring|June 1, 1987
Quantitative determination of phenobarbital and phenytoin by dry-phase apoenzyme reactivation immunoassay system (ARIS)D Croci, A Nespolo, G TarenghiClinical Chemistry|February 1, 1988
A dry-reagent strip for quantifying carbamazepine evaluatedD Croci, A Nespolo, G TarenghiTherapeutic Drug Monitoring|January 22, 2002
New high-performance liquid chromatographic method for plasma/serum analysis of lamotrigineD Croci, A Salmaggi, U de Grazia, et al.Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|November 1, 1989
A simple immunoturbidimetric method for IgG and albumin quantitation in cerebrospinal fluid and serumD Croci, A Nespolo, M A Bosoni, et al.Therapeutic Drug Monitoring|October 1, 1992
Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepineD Battino, D Croci, T Granata, et al.Italian Journal of Neurological Sciences|October 1, 1992
Neoadjuvant chemotherapy in the treatment of recurrent glioblastomas (GBM)A Boiardi, A Silvani, D Croci, et al.Therapeutic Drug Monitoring|May 22, 2001
Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedicationD Battino, D Croci, T Granata, et al.Therapeutic Drug Monitoring|January 8, 1998
Lamotrigine plasma concentrations in children and adults: influence of age and associated therapyD Battino, D Croci, T Granata, et al.Italian Journal of Neurological Sciences|September 1, 1994
Primary antiphospholipid syndrome (PAPS) and isolated partial seizures in adolescence. A case reportR Spreafico, S Binelli, M G Bruzzone, et al.Therapeutic Drug Monitoring|January 1, 1983
Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapyD Battino, G Avanzini, L Bossi, et al.Pageof 3